Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$513M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$412M |
| 3 |
Meta Platforms (Facebook)
META
|
+$354M |
| 4 |
ServiceNow
NOW
|
+$262M |
| 5 |
American Airlines Group
AAL
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$571M |
| 2 |
Apple
AAPL
|
+$571M |
| 3 |
Netflix
NFLX
|
+$388M |
| 4 |
NVIDIA
NVDA
|
+$313M |
| 5 |
TSMC
TSM
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.32% |
| 2 | Healthcare | 15.28% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 11.11% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Deutsche Bank
DB
$71.5B
| $299K | ﹤0.01% |
+12,722
| New | +$267K |
|
2927
TELA Bio
TELA
$38.9M
| $298K | ﹤0.01% |
244,444
-180,696
| -43% | -$444K |
|
2928
Data Storage Corp
DTST
$7.81M
| $297K | ﹤0.01% |
81,900
-1,200
| -1% | -$4.88K |
|
|
ITRM
2929
DELISTED
Iterum Therapeutics
ITRM
| $296K | ﹤0.01% |
240,900
-197,916
| -45% | -$294K |
|
2930
Morgan Stanley Direct Lending Fund
MSDL
$1.31B
| $295K | ﹤0.01% |
14,764
-337,936
| -96% | -$6.99M |
|
|
RPTX
2931
DELISTED
Repare Therapeutics
RPTX
| $294K | ﹤0.01% |
298,661
-48,799
| -14% | -$58.8K |
|
|
LITS
2932
Lite Strategy Inc
LITS
$30.9M
| $294K | ﹤0.01% |
134,446
-500
| -0.4% | -$1.3K |
|
2933
Educational Development Corp
EDUC
$11.8M
| $294K | ﹤0.01% |
214,845
-7,700
| -3% | -$11.5K |
|
2934
Bridgeline Digital
BLIN
$14.4M
| $294K | ﹤0.01% |
198,529
+67,625
| +52% | +$112K |
|
2935
Century Casinos
CNTY
$34M
| $293K | ﹤0.01% |
173,149
+2,200
| +1% | +$5.97K |
|
2936
Rapid Micro Biosystems
RPID
$86.2M
| $292K | ﹤0.01% |
110,587
-72,500
| -40% | -$165K |
|
2937
Bogota Financial
BSBK
$111M
| $290K | ﹤0.01% |
37,851
| – | – |
|
|
MRSN
2938
DELISTED
Mersana Therapeutics
MRSN
| $289K | ﹤0.01% |
33,597
+9,346
| +39% | +$144K |
|
2939
Comscore
SCOR
$109M
| $289K | ﹤0.01% |
42,021
-3,415
| -8% | -$22.8K |
|
2940
Heartland Express
HTLD
$956M
| $284K | ﹤0.01% |
+30,800
| New | +$326K |
|
2941
Vanguard Materials ETF
VAW
$3.13B
| $283K | ﹤0.01% |
1,500
-2,300
| -61% | -$446K |
|
|
ACCS
2942
ACCESS Newswire
ACCS
$26.2M
| $283K | ﹤0.01% |
32,038
-3,700
| -10% | -$34.9K |
|
2943
Acumen Pharmaceuticals
ABOS
$176M
| $282K | ﹤0.01% |
256,700
-513
| -0.2% | -$733 |
|
|
STLN
2944
Starling Oncology, Inc. Common Stock
STLN
$641M
| $282K | ﹤0.01% |
247,600
+65,600
| +36% | +$50.8K |
|
2945
iShares Select Dividend ETF
DVY
$23.6B
| $282K | ﹤0.01% |
+2,100
| New | +$282K |
|
2946
YieldMax Ultra Option Income Strategy ETF
ULTY
$782M
| $281K | ﹤0.01% |
4,650
-1,195
| -20% | -$93.2K |
|
|
ZENV
2947
DELISTED
Zenvia
ZENV
| $281K | ﹤0.01% |
133,201
+32,800
| +33% | +$69.9K |
|
2948
GrowGeneration
GRWG
$90.7M
| $281K | ﹤0.01% |
260,186
+5,076
| +2% | +$6.81K |
|
2949
Ark Restaurants
ARKR
$20.2M
| $279K | ﹤0.01% |
27,611
-200
| -0.7% | -$2.39K |
|
2950
Coca-Cola
KO
$375B
| $278K | ﹤0.01% |
3,898
-1,115
| -22% | -$74.5K |
|
Similar funds
Renaissance Technologies's Q1 2025 Portfolio in Review
As of Q1 2025, Renaissance Technologies held 3,989 positions worth $66.1B, down 2.2% from $67.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2025 filing shows 456 new, 1,472 increased, 1,441 reduced and 583 closed positions. Its largest new stake was ServiceNow: 1,361,505 shares worth $217M. The largest sale was Palantir, an estimated $571M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2025 buy was ServiceNow: 1,361,505 shares worth $217M.
- Renaissance Technologies added most to Broadcom in Q1 2025, an estimated $513M increase.
- Renaissance Technologies's biggest Q1 2025 reduction was Palantir, cutting an estimated $571M.
- Renaissance Technologies fully exited Nike in Q1 2025, selling an estimated $197M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.1B portfolio in Q1 2025.
- Renaissance Technologies opened 456 new positions and closed 583 in Q1 2025.
- Renaissance Technologies's portfolio value fell 2.2% quarter-over-quarter to $66.1B.
Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.